MedWatch

Zealand Pharma Chief Medical Officer sells shares worth USD 650,000

Adam Steensberg, Chief Medical Officer and Head of Research and Development at Zealand Pharma, has sold 20,000 shares in the company.

Adam Steensberg, Chief Medical Officer and Head of Research and Development | Photo: Zealand Pharma

Zealand Pharma’s Head of Research and Development Adam Steensberg has sold shares worth USD 655,000 (DKK 4.1m), the company reports in a statement.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs